Karnataka minister writes to poll panel seeking EVM challenge

News Network
January 2, 2018

Priyank Kharge, Karnataka Minister for IT and BT, on Tuesday, wrote to the Election Commission of India (ECI), seeking an electronic voting machine (EVM) challenge to test the machines for errors.

In his letter to Achal Kumar Jyoti, the Chief Election Commissioner, Kharge has proposed that the EVM challenge be jointly hosted by the Karnataka government and the ECI, where stakeholders of the scientific community can be invited to participate in testing the EVMs.

Unlike the EVM challenge hosted by the ECI in May 2017, where only political parties participated, Kharge has said that the challenge this time should be thrown open to technocrats, scientists, corporates, R&D institutes, start-ups and tinkerers.

He has sought that the ECI provide 250 randomly selected EVMs to plan and execute the challenge, under the overall supervision of the ECI.

For the challenge, individuals or interested parties can be allowed to test the EVMs using instruments of their choice. Design documents, test descriptions and results, security procedures used by the ECI can be provided for the same. Results obtained can be made public and long-term testing by a team of experts can be initiated, if necessary, he has said.

"The challenge needs to go beyond political parties and should be opened to all the young and bright minds in the country to ensure a pure scientific engagement with the community without political agenda. If there are technical flaws, we can solve it together and if there are no errors, we restore the people's faith in our democratic process," his letter states.

Comments

Wellwisher
 - 
Tuesday, 2 Jan 2018

At Karnataka who wver won that is people selection but to elect election commission must stop EVM system and replace Ballot voting system. Karnataka always support and electing a wisa and qualified Desh Bjakth candidate, So please respect our voting power a d implement Bllot voting system.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 4,2020

Bagalkot, April 4: A COVID-19 positive patient passed away in Karnataka's Bagalkot on Friday, taking the total number of deaths in the state to four, informed the Deputy Commissioner of Bagalkot.

The total number of coronavirus cases in the country now stands at 2650 including 184 people who have been discharged or cured or migrated, and 68 deaths, as per the data provided by the Ministry of Health and Family Welfare.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
April 19,2020

Mangaluru, Apr 19: In order to boost the Coast Guard's (CG) surveillance and reconnaissance capabilities on the country's west coast in Karnataka, CG OPV Varaha and CG Dornier 785 ex Kochi were pressed to service to undertake extensive surveillance.

"Both seawards and aerial surveillance of Karnataka coast line will be undertaken from Sunday," said S Babu Venkatesh, Commander, Coast Guard, Karnataka. The surveillance will be an air-sea coordinated operation.

The Coast Guard ships and aircraft maintained extensive search in the area for intercepting any suspect vessel. Indian Coast Guard ships classified various contacts in the area and kept them under constant surveillance.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.